Myriad's myRisk Hereditary Cancer Test Improves Colon Cancer Testing By 60 Percent

Myriad Genetics announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps.
FirstWord MedTech